PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on PTCT
    PTC Therapeutics to Participate in Upcoming Investor Conferences
    8:00a ET May 4 '26 PR Newswire

    PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences:

    Bank of America Securities Health Care Conference 2026 Tuesday, May 12 at 8:40 a.m. PDT / 11:40 a.m. EDT

    RBC Capital Markets 2026 Global Healthcare Conference Wednesday, May 20 at 10 a.m. EDT

    Goldman Sachs 47th Annual Global Healthcare Conference Tuesday, June 9 at 9:20 a.m. EDT

    The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation.

    About PTC Therapeutics, Inc. PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow us on LinkedIn, X, Instagram and Facebook.

    For more information, please contact:

    Investors: Ellen Cavaleri+1 (615) 618-8228ecavaleri@ptcbio.com

    Media: Jeanine Clemente+1 (908) 912-9406jclemente@ptcbio.com

    View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-in-upcoming-investor-conferences-302760778.html

    SOURCE PTC Therapeutics, Inc.

    https://rt.newswire.ca/rt.gif?NewsItemId=NY49470&Transmission_Id=202605040800PR_NEWS_USPR_____NY49470&DateId=20260504

    COMTEX_478498768/1005/2026-05-04T08:00:48

    PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule ...
    4:30p ET June 17 '26 PR Newswire
    PTC Therapeutics Announces Pricing of Convertible Notes Offering to R...
    11:16p ET June 15 '26 PR Newswire
    PTC Therapeutics Announces Pricing of Convertible Notes Offering to R...
    11:16p ET June 15 '26 PR Newswire
    PTC Therapeutics Announces Proposed Convertible Notes Offering to Ref...
    7:00a ET June 15 '26 PR Newswire
    PTC Therapeutics Announces Proposed Convertible Notes Offering to Ref...
    6:59a ET June 15 '26 PR Newswire
    PTC Therapeutics Provides Corporate Update and Reports First Quarter ...
    4:01p ET May 7 '26 PR Newswire
    PTC Therapeutics Provides Corporate Update and Reports First Quarter ...
    4:01p ET May 7 '26 PR Newswire
    PTC Therapeutics to Participate in Upcoming Investor Conferences
    8:00a ET May 4 '26 PR Newswire
    PTC Therapeutics to Participate in Upcoming Investor Conferences
    8:00a ET May 4 '26 PR Newswire
    PTC Therapeutics to Report First Quarter 2026 Financial Results on Th...
    8:00a ET April 22 '26 PR Newswire

    Market data provided by News provided by